
Article 1 
The first watch list of substances for Union-wide monitoring referred to in Article 8b of Directive 2008/105/EC is set out in the Annex to this Decision.
Article 2 
This Decision is addressed to the Member States.
Done at Brussels, 20 March 2015.
For the Commission
Karmenu VELLA
Member of the Commission
ANNEX

Name of substance/group of substances CAS number EU number Indicative analytical method Maximum acceptable method detection limit (ng/l)
17-Alpha-ethinylestradiol (EE2) 57-63-6 200-342-2 Large-volume SPE — LC-MS-MS 0,035
17-Beta-estradiol (E2), Estrone (E1) 50-28-2,53-16-7 200-023-8 SPE — LC-MS-MS 0,4
Diclofenac 15307-86-5 239-348-5 SPE — LC-MS-MS 10
2,6-Ditert-butyl-4-methylphenol 128-37-0 204-881-4 SPE — GC-MS 3 160
2-Ethylhexyl 4-methoxycinnamate 5466-77-3 226-775-7 SPE — LC-MS-MSor GC-MS 6 000
Macrolide antibiotics   SPE — LC-MS-MS 90
Methiocarb 2032-65-7 217-991-2 SPE — LC-MS-MSor GC-MS 10
Neonicotinoids   SPE — LC-MS-MS 9
Oxadiazon 19666-30-9 243-215-7 LLE/SPE — GC-MS 88
Tri-allate 2303-17-5 218-962-7 LLE/SPE — GC-MSor LC-MS-MS 670






